ANTIPLATELET THERAPY AFTER CORONARY ARTERY BYPASS GRAFT SURGERY – UNEVENNESS OF DAILY CLINICAL PRACTICE

Antiplatelet therapy is an integral part of optimal medicamentous therapy in patients with coronary artery disease. The strategy of antiplatelet/anticoagulant therapy is adjusted (combination of drugs, dosing and duration of therapy) depending on the stage of the disease (acute coronary syndrome wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Sopek-Merkaš, Ivana, Lakušić, Nenad, Fučkar, Krunoslav, Cerovec, Duško, Bešić, Kristina Marić
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sestre Milosrdnice University Hospital and Institute of Clinical Medical Research, Vinogradska cesta c. 29 Zagreb 2021
Materias:
Preliminary Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8907948/
https://www.ncbi.nlm.nih.gov/pubmed/35282474
http://dx.doi.org/10.20471/acc.2021.60.03.26
_version_ 1784665767807025152
author Sopek-Merkaš, Ivana
Lakušić, Nenad
Fučkar, Krunoslav
Cerovec, Duško
Bešić, Kristina Marić
author_facet Sopek-Merkaš, Ivana
Lakušić, Nenad
Fučkar, Krunoslav
Cerovec, Duško
Bešić, Kristina Marić
author_sort Sopek-Merkaš, Ivana
collection PubMed
description Antiplatelet therapy is an integral part of optimal medicamentous therapy in patients with coronary artery disease. The strategy of antiplatelet/anticoagulant therapy is adjusted (combination of drugs, dosing and duration of therapy) depending on the stage of the disease (acute coronary syndrome with percutaneous coronary intervention, chronic coronary syndrome, or coronary surgical revascularization) and comorbidity of each patient (e.g., atrial fibrillation, left ventricular thrombus, etc.). Guidelines and clinical practice in particular are not uniform and specific regarding dual antiplatelet therapy in patients undergoing coronary artery bypass grafting, especially in the setting of chronic coronary syndrome.
format Online
Article
Text
id pubmed-8907948
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Sestre Milosrdnice University Hospital and Institute of Clinical Medical Research, Vinogradska cesta c. 29 Zagreb
record_format MEDLINE/PubMed
spelling pubmed-89079482022-03-11 ANTIPLATELET THERAPY AFTER CORONARY ARTERY BYPASS GRAFT SURGERY – UNEVENNESS OF DAILY CLINICAL PRACTICE Sopek-Merkaš, Ivana Lakušić, Nenad Fučkar, Krunoslav Cerovec, Duško Bešić, Kristina Marić Acta Clin Croat Preliminary Communications Antiplatelet therapy is an integral part of optimal medicamentous therapy in patients with coronary artery disease. The strategy of antiplatelet/anticoagulant therapy is adjusted (combination of drugs, dosing and duration of therapy) depending on the stage of the disease (acute coronary syndrome with percutaneous coronary intervention, chronic coronary syndrome, or coronary surgical revascularization) and comorbidity of each patient (e.g., atrial fibrillation, left ventricular thrombus, etc.). Guidelines and clinical practice in particular are not uniform and specific regarding dual antiplatelet therapy in patients undergoing coronary artery bypass grafting, especially in the setting of chronic coronary syndrome. Sestre Milosrdnice University Hospital and Institute of Clinical Medical Research, Vinogradska cesta c. 29 Zagreb 2021-09 /pmc/articles/PMC8907948/ /pubmed/35282474 http://dx.doi.org/10.20471/acc.2021.60.03.26 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (CC BY-NC-ND) 4.0 License.
spellingShingle Preliminary Communications
Sopek-Merkaš, Ivana
Lakušić, Nenad
Fučkar, Krunoslav
Cerovec, Duško
Bešić, Kristina Marić
ANTIPLATELET THERAPY AFTER CORONARY ARTERY BYPASS GRAFT SURGERY – UNEVENNESS OF DAILY CLINICAL PRACTICE
title ANTIPLATELET THERAPY AFTER CORONARY ARTERY BYPASS GRAFT SURGERY – UNEVENNESS OF DAILY CLINICAL PRACTICE
title_full ANTIPLATELET THERAPY AFTER CORONARY ARTERY BYPASS GRAFT SURGERY – UNEVENNESS OF DAILY CLINICAL PRACTICE
title_fullStr ANTIPLATELET THERAPY AFTER CORONARY ARTERY BYPASS GRAFT SURGERY – UNEVENNESS OF DAILY CLINICAL PRACTICE
title_full_unstemmed ANTIPLATELET THERAPY AFTER CORONARY ARTERY BYPASS GRAFT SURGERY – UNEVENNESS OF DAILY CLINICAL PRACTICE
title_short ANTIPLATELET THERAPY AFTER CORONARY ARTERY BYPASS GRAFT SURGERY – UNEVENNESS OF DAILY CLINICAL PRACTICE
title_sort antiplatelet therapy after coronary artery bypass graft surgery – unevenness of daily clinical practice
topic Preliminary Communications
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8907948/
https://www.ncbi.nlm.nih.gov/pubmed/35282474
http://dx.doi.org/10.20471/acc.2021.60.03.26
work_keys_str_mv AT sopekmerkasivana antiplatelettherapyaftercoronaryarterybypassgraftsurgeryunevennessofdailyclinicalpractice
AT lakusicnenad antiplatelettherapyaftercoronaryarterybypassgraftsurgeryunevennessofdailyclinicalpractice
AT fuckarkrunoslav antiplatelettherapyaftercoronaryarterybypassgraftsurgeryunevennessofdailyclinicalpractice
AT cerovecdusko antiplatelettherapyaftercoronaryarterybypassgraftsurgeryunevennessofdailyclinicalpractice
AT besickristinamaric antiplatelettherapyaftercoronaryarterybypassgraftsurgeryunevennessofdailyclinicalpractice

Ejemplares similares